Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Journal of Virology
|
March 1, 1990
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein
N Dyson, R Bernards, S H Friend, et al.
Molecular and Cellular Biology
|
August 1, 1997
The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain
A Srinivasan, A J McClellan, J Vartikar, et al.
Cancer Research
|
November 1, 1992
Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors
M F Melhem, A I Meisler, G G Finley, et al.
Molecular Cell
|
September 13, 2000
Loss of E2F4 activity leads to abnormal development of multiple cellular lineages
R E Rempel, M T Saenz-Robles, R Storms, et al.
Genes & Development
|
May 1, 1997
DnaJ/hsp40 chaperone domain of SV40 large T antigen promotes efficient viral DNA replication
K S Campbell, K P Mullane, I A Aksoy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2001
Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas
J M Pipas, S E Mitchell, R J Barth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2020
Corrigendum to 'Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)': Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79-87
M Kundranda, A C Gracian, S F Zafar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)
M Kundranda, A C Gracian, S F Zafar, et al.
Medical and Pediatric Oncology
|
June 1, 1996
Treatment of patients with pineoblastoma with high dose cyclophosphamide
D M Ashley, D Longee, R Tien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2012
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma
J M Pipas, B I Zaki, M M McGowan, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Journal of Virology
|
March 1, 1990
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein
N Dyson, R Bernards, S H Friend, et al.
Molecular and Cellular Biology
|
August 1, 1997
The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain
A Srinivasan, A J McClellan, J Vartikar, et al.
Cancer Research
|
November 1, 1992
Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors
M F Melhem, A I Meisler, G G Finley, et al.
Molecular Cell
|
September 13, 2000
Loss of E2F4 activity leads to abnormal development of multiple cellular lineages
R E Rempel, M T Saenz-Robles, R Storms, et al.
Genes & Development
|
May 1, 1997
DnaJ/hsp40 chaperone domain of SV40 large T antigen promotes efficient viral DNA replication
K S Campbell, K P Mullane, I A Aksoy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2001
Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas
J M Pipas, S E Mitchell, R J Barth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2020
Corrigendum to 'Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)': Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79-87
M Kundranda, A C Gracian, S F Zafar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)
M Kundranda, A C Gracian, S F Zafar, et al.
Medical and Pediatric Oncology
|
June 1, 1996
Treatment of patients with pineoblastoma with high dose cyclophosphamide
D M Ashley, D Longee, R Tien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2012
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma
J M Pipas, B I Zaki, M M McGowan, et al.
Page
of 8